2'-(N-Methylanthraniloyl)guanosine 3',5'-Cyclicmonophosphate, Sodium Salt
2'-(N-Methylanthraniloyl)guanosine 3',5'-Cyclicmonophosphate, Sodium Salt(221905-46-0)
- Name: 2'-(N-Methylanthraniloyl)guanosine 3',5'-Cyclicmonophosphate, Sodium Salt
- Synonyms:Cyclic 3,5-(hydrogen phosphate) 2-[2-(MethylaMino)benzoate] Guanosine MonosodiuM Salt
- Molecular Formula:C18H19 N6 O8 P . Na
- Molecular Weight:500.338
- CAS Registry Number:221905-46-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.221905-46-0 2'-(N-Methylanthraniloyl)guanosine 3',5'-Cyclicmonophosphate, Sodium Salt
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.221905-46-0 2'-(N-Methylanthraniloyl)guanosine 3',5'-Cyclicmonophosphate, Sodium Salt
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:2'-(N-Methylanthraniloyl)guanosine 3',5'-Cyclicmonophosphate, Sodium Salt
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.221905-46-0 2'-(N-METHYLANTHRANILOYL) GUANOSINE 3',5'-CYCLIC ...
Assay:97% Appearance:Contact us for details Package:According to the requirements of customer Storage:Store in a tightly closed container in a cool and dry place. Transportation:Door to door by Fedex/DHL or by air Application:Research & Development
Min. Order:1Milligram
Supplier:NewCan Biotech Limited [
China (Mainland)] CAS No.221905-46-0 2'-(N-Methylanthraniloyl)guanosine 3',5'-Cyclicmonophosphate, Sodium Salt
Assay:95% Appearance:off-white powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 222036-21-7/Acetamide, N-6-benzothiazolyl-2-(hydroxyimino)- (9CI)
- 33209-25-5/1,2-Cyclohexanedicarbonyl dichloride, trans-(+)- (9CI)
- 367-79-3/ETHYL 2-FLUORO-5-NITROBENZOATE
- 33208-98-9/H-PRO-NHCH3 HCL
- 222021-73-0/Acetamide, 2-hydroxy-N-methyl-N-(2-oxoethyl)- (9CI)
- 222018-18-0/LYN PEPTIDE INHIBITOR
- 33208-47-8/.beta.-D-Mannopyranose, 1,6:2,3-dianhydro-4-O-(phenylmethyl)-
- 33207-70-4/Ethanone, 1-(1,3-dimethyl-1H-pyrrol-2-yl)- (9CI)
- 221911-75-7/2-Pyrrolidinol, 1-acetyl-, acetate (ester), (2S)- (9CI)
- 33206-18-7/4-Pyridinepropanoicacid,-bta--hydroxy-(9CI)
- 221911-70-2/Butanoic acid, (2S)-2-pyrrolidinyl ester (9CI)
- 33205-61-7/Pregn-4-ene-3,20-dione, 11beta,17,21-trihydroxy-16-methylene-, tris(tr ifluoroacetate)
- 221911-62-2/2-Pyrrolidinol, 1-acetyl-, acetate (ester), (2R)- (9CI)
- 221911-57-5/Butanoic acid, (2R)-2-pyrrolidinyl ester (9CI)
- 221909-12-2/Cyclohexanemethanol, 2-(1-methylethyl)- (9CI)
- 33204-57-8/Pentylamine, 1-sec-butyl-4-methyl-, (+)- (8CI)
- 33204-46-5/(2S)-2-METHYL-1,2-BUTANEDIOL
- 221908-14-1/4-AZIDO-2,3,5,6-TETRAFLUOROBENZOIC ACID STP ESTER SODIUM SALT
- 367-69-1/1-[4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL]ETHAN-1-OL
- 221905-46-0/2'-(N-Methylanthraniloyl)guanosine 3',5'-Cyclicmonophosphate, Sodium Salt
- 33201-99-9/beta-Aminoatroponitrile
- 33201-24-0/Tricyclo[2.2.1.02,6]heptan-3-ol, 1-ethyl-, acetate, stereoisomer (8CI,9CI)
- 221905-18-6/3-Benzofuranmethanol, 6-hydroxy-
- 33201-23-9/Tricyclo[2.2.1.02,6]heptan-3-ol, 1-ethyl-, acetate, stereoisomer (8CI,9CI)
- 221899-88-3/2,4'-DDT D8
- 33197-77-2/TRANS-4-[2-(1-FERROCENYL)VINYL]-1-METHYLPYRIDINIUM IODIDE
- 221895-82-5/5-(ALLYLOXYCARBONYLAMINO)-1-PENTANOL
- 33192-65-3/4H-Furo[2,3-f]indazole
- 221893-57-8/Imidazo[1,2-a]pyridine-3-carboxylic acid, 2-amino-, ethyl ester (9CI)
- 221892-32-6/1-Naphthalenecarboxaldehyde,7-ethoxy-1,2,3,4-tetrahydro-(9CI)